| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 6100879 | Journal of Crohn's and Colitis | 2008 | 6 Pages |
Abstract
The literature review revealed an up to four-fold increased risk of demyelinating diseases, in particular MS, in IBD patients in general. The risk of developing MS in the anti-TNFα treated Danish cohort did apparently not exceed this risk.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Gastroenterology
Authors
Nynne Nyboe Andersen, Sarah Caspersen, Tine Jess, Pia Munkholm,